Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients

This study investigated the safety and efficacy of mirogabalin, a novel, potent, selective ligand of the α(2)δ subunit of voltage-dependent Ca(2+) channels, for the treatment of postherpetic neuralgia (PHN). In this multicenter, double-blind, placebo-controlled phase 3 study, Asian patients ≥20 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Jitsu, Matsui, Norimitsu, Kakehi, Yoshihiro, Murayama, Emiko, Ohwada, Shoichi, Sugihara, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485311/
https://www.ncbi.nlm.nih.gov/pubmed/30913164
http://dx.doi.org/10.1097/j.pain.0000000000001501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485311/
https://www.ncbi.nlm.nih.gov/pubmed/30913164
http://dx.doi.org/10.1097/j.pain.0000000000001501

Ejemplares similares